Authors:
Rothman, AL
Kanesa-thasan, N
West, K
Janus, J
Saluzzo, JF
Ennis, FA
Citation: Al. Rothman et al., Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine, VACCINE, 19(32), 2001, pp. 4694-4699
Authors:
Kanesa-thasan, N
Sun, W
Kim-Ahn, G
Van Albert, S
Putnak, JR
King, A
Raengsakulsrach, B
Christ-Schmidt, H
Gilson, K
Zahradnik, JM
Vaughn, DW
Innis, BL
Saluzzo, JF
Hoke, CH
Citation: N. Kanesa-thasan et al., Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers, VACCINE, 19(23-24), 2001, pp. 3179-3188
Authors:
Houng, HSH
Chen, RCM
Vaughn, DW
Kanesa-thasan, N
Citation: Hsh. Houng et al., Development of a fluorogenic RT-PCR system for quantitative identificationof dengue virus serotypes 1-4 using conserved and serotype-specific 3 ' noncoding sequences, J VIROL MET, 95(1-2), 2001, pp. 19-32
Authors:
Kanesa-thasan, N
Smucny, JJ
Hoke, CH
Marks, DH
Konishi, E
Kurane, I
Tang, DB
Vaughn, DW
Mason, PW
Shope, RE
Citation: N. Kanesa-thasan et al., Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus - poxvirus vaccines in vaccinia-nonimmune andvaccinia-immune humans, VACCINE, 19(4-5), 2000, pp. 483-491
Citation: Hsh. Houng et al., Quantitative detection of dengue 2 virus using fluorogenic RT-PCR based on3 '-noncoding sequence, J VIROL MET, 86(1), 2000, pp. 1-11